Ovid Therapeutics Inc (OVID)
3.00
-0.05
(-1.64%)
USD |
NASDAQ |
May 10, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Shareholders Equity (Quarterly): 87.80M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 87.80M |
| September 30, 2023 | 101.29M |
| June 30, 2023 | 110.70M |
| March 31, 2023 | 120.95M |
| December 31, 2022 | 132.27M |
| September 30, 2022 | 142.05M |
| June 30, 2022 | 152.15M |
| March 31, 2022 | 165.00M |
| December 31, 2021 | 179.75M |
| September 30, 2021 | 197.02M |
| June 30, 2021 | 206.71M |
| March 31, 2021 | 221.11M |
| December 31, 2020 | 43.63M |
| September 30, 2020 | 63.64M |
| June 30, 2020 | 30.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 51.44M |
| December 31, 2019 | 70.02M |
| September 30, 2019 | 30.05M |
| June 30, 2019 | 45.44M |
| March 31, 2019 | 57.25M |
| December 31, 2018 | 38.81M |
| September 30, 2018 | 49.97M |
| June 30, 2018 | 61.12M |
| March 31, 2018 | 72.09M |
| December 31, 2017 | 83.44M |
| September 30, 2017 | 92.96M |
| June 30, 2017 | 100.94M |
| March 31, 2017 | 42.34M |
| December 31, 2016 | 49.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
30.05M
Minimum
Sep 2019
221.11M
Maximum
Mar 2021
113.24M
Average
110.70M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 806.52M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 144.03M |
| Total Liabilities (Quarterly) | 56.23M |
| Current Ratio | 9.552 |